Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation (Q35634488)

9 August 2017

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation (English)

1 reference

inflammatory bowel diseases

9 August 2017

0 references

0 references

Anne Salonen

6

0 references

Willem de Vos

7

object named as

Willem M de Vos

1 reference

9 August 2017

Kaija-Leena Kolho

1

1 reference

9 August 2017

Katri Korpela

2

1 reference

9 August 2017

Tytti Jaakkola

3

1 reference

9 August 2017

Madharasi V A Pichai

4

1 reference

9 August 2017

Erwin G Zoetendal

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

19 May 2015

1 reference

The American Journal of Gastroenterology

9 August 2017

1 reference

9 August 2017

110

1 reference

9 August 2017

921-930

1 reference

9 August 2017

6

1 reference

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

9 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Population-based cases control study of inflammatory bowel disease risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

The microbiome in inflammatory bowel disease: current status and the future ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Antibiotic use and inflammatory bowel diseases in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Long-term efficacy of adalimumab in paediatric Crohn's disease patients naïve to other anti-TNF therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Infliximab dependency in pediatric Crohn's disease: long-term follow-up of an unselected cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

The treatment-naive microbiome in new-onset Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Alterations in the gut microbiome of children with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

A fully scalable online pre-processing algorithm for short oligonucleotide microarray atlases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

pROC: an open-source package for R and S+ to analyze and compare ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Multimodel Inference: Understanding AIC and BIC in Model Selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Inflammatory bowel disease as a model for translating the microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Tipping elements in the human intestinal ecosystem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Multivariable geostatistics in S: the gstat package

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.149

Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria

21 January 2018

1 reference

12 December 2020

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents

1 reference

12 December 2020

Skin reactions during anti-TNFα therapy for pediatric inflammatory bowel disease: a 2-year prospective study

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

1 reference

12 December 2020

The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases

1 reference

12 December 2020

Long-term outcome of maintenance infliximab therapy in children with Crohnʼs disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2015.149

1 reference

9 August 2017

1 reference